loading

Finanzdaten der Crinetics Pharmaceuticals Inc-Aktie (CRNX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
0.64
- 0.346 0.988 2.679
Operating Expenses
18.37%
74.17
62.66 59.32 53.98 50.66
Benefits Costs and Expenses
100.00%
-
218.54 - - -
Costs And Expenses
35.89%
74.17
54.58 59.32 53.98 50.66
Depreciation and Amortization
80.92%
0.474
0.262 0.273 0.28 0.283
Operating Income/Loss
17.35%
-73.53
-62.66 -58.98 -52.99 -47.98
Nonoperating Income/Loss
4.54%
7.069
6.762 2.516 2.016 1.983
Income/Loss From Continuing Operations Before Tax
100.29%
0.64
-218.54 0.346 0.988 2.679
Income/Loss From Continuing Operations After Tax
11.37%
-66.93
-60.10 -57.46 -50.98 -45.99
Net Income/Loss
11.37%
-66.93
-60.10 -57.46 -50.98 -45.99
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
2,256%
72.29
3.068 56.81 54.27 53.91
Diluted Average Shares
2,256%
72.29
3.068 56.81 54.27 53.91
Basic Earnings Per Share
5.68%
-0.93
-0.88 -1.01 -0.94 -0.85
Diluted Earnings Per Share
5.68%
-0.93
-0.88 -1.01 -0.94 -0.85
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.99
price up icon 1.91%
$71.40
price down icon 0.28%
$32.90
price up icon 0.11%
$23.21
price down icon 1.78%
$104.43
price up icon 0.23%
biotechnology ONC
$263.58
price up icon 5.77%
Kapitalisierung:     |  Volumen (24h):